Global Artificial Intelligence in Diabetes Management Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI02241212

Publication Date:

February 28, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

The global Artificial Intelligence in Diabetes Management market size was valued at US$ million in 2023. With growing demand in downstream market, the Artificial Intelligence in Diabetes Management is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Artificial Intelligence in Diabetes Management market. Artificial Intelligence in Diabetes Management are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artificial Intelligence in Diabetes Management. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artificial Intelligence in Diabetes Management market.
Artificial Intelligence in diabetes management is an automotion system which employs a computer system that gathers data, understands, reasons, and learns how the information effects outcomes over time.That the system ingests massive amounts of information鈥攂oth structured and unstructured data鈥攕uch as databases that have categorical variables, health records, and the scientific lexicon in research papers all of which is ingested and processed to make connections and then draw conclusions through a process of learning over time to increase in accuracy.
As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate 鈧�9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.26%, including software, hardware and services.
Key Features:
The report on Artificial Intelligence in Diabetes Management market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Artificial Intelligence in Diabetes Management market. It may include historical data, market segmentation by Type (e.g., Case-based Reasoning, Intelligent Data Analysis), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artificial Intelligence in Diabetes Management market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Artificial Intelligence in Diabetes Management market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Artificial Intelligence in Diabetes Management industry. This include advancements in Artificial Intelligence in Diabetes Management technology, Artificial Intelligence in Diabetes Management new entrants, Artificial Intelligence in Diabetes Management new investment, and other innovations that are shaping the future of Artificial Intelligence in Diabetes Management.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artificial Intelligence in Diabetes Management market. It includes factors influencing customer ' purchasing decisions, preferences for Artificial Intelligence in Diabetes Management product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artificial Intelligence in Diabetes Management market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artificial Intelligence in Diabetes Management market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artificial Intelligence in Diabetes Management market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artificial Intelligence in Diabetes Management industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artificial Intelligence in Diabetes Management market.
Market Segmentation:
Artificial Intelligence in Diabetes Management market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Case-based Reasoning
Intelligent Data Analysis
Segmentation by application
Glucose Monitoring Devices
Diagnostic Devices
Insulin Delivery Devices
Other Devices
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Apple
Diabnext
Glooko
Google
IBM
Tidepool
Vodafone

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Intelligence in Diabetes Management Market Size 2019-2030
2.1.2 Artificial Intelligence in Diabetes Management Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Artificial Intelligence in Diabetes Management Segment by Type
2.2.1 Case-based Reasoning
2.2.2 Intelligent Data Analysis
2.3 Artificial Intelligence in Diabetes Management Market Size by Type
2.3.1 Artificial Intelligence in Diabetes Management Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Artificial Intelligence in Diabetes Management Market Size Market Share by Type (2019-2024)
2.4 Artificial Intelligence in Diabetes Management Segment by Application
2.4.1 Glucose Monitoring Devices
2.4.2 Diagnostic Devices
2.4.3 Insulin Delivery Devices
2.4.4 Other Devices
2.5 Artificial Intelligence in Diabetes Management Market Size by Application
2.5.1 Artificial Intelligence in Diabetes Management Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Artificial Intelligence in Diabetes Management Market Size Market Share by Application (2019-2024)
3 Artificial Intelligence in Diabetes Management Market Size by Player
3.1 Artificial Intelligence in Diabetes Management Market Size Market Share by Players
3.1.1 Global Artificial Intelligence in Diabetes Management Revenue by Players (2019-2024)
3.1.2 Global Artificial Intelligence in Diabetes Management Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence in Diabetes Management Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Intelligence in Diabetes Management by Regions
4.1 Artificial Intelligence in Diabetes Management Market Size by Regions (2019-2024)
4.2 Americas Artificial Intelligence in Diabetes Management Market Size Growth (2019-2024)
4.3 APAC Artificial Intelligence in Diabetes Management Market Size Growth (2019-2024)
4.4 Europe Artificial Intelligence in Diabetes Management Market Size Growth (2019-2024)
4.5 Middle East & Africa Artificial Intelligence in Diabetes Management Market Size Growth (2019-2024)
5 Americas
5.1 Americas Artificial Intelligence in Diabetes Management Market Size by Country (2019-2024)
5.2 Americas Artificial Intelligence in Diabetes Management Market Size by Type (2019-2024)
5.3 Americas Artificial Intelligence in Diabetes Management Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence in Diabetes Management Market Size by Region (2019-2024)
6.2 APAC Artificial Intelligence in Diabetes Management Market Size by Type (2019-2024)
6.3 APAC Artificial Intelligence in Diabetes Management Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Intelligence in Diabetes Management by Country (2019-2024)
7.2 Europe Artificial Intelligence in Diabetes Management Market Size by Type (2019-2024)
7.3 Europe Artificial Intelligence in Diabetes Management Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Intelligence in Diabetes Management by Region (2019-2024)
8.2 Middle East & Africa Artificial Intelligence in Diabetes Management Market Size by Type (2019-2024)
8.3 Middle East & Africa Artificial Intelligence in Diabetes Management Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Artificial Intelligence in Diabetes Management Market Forecast
10.1 Global Artificial Intelligence in Diabetes Management Forecast by Regions (2025-2030)
10.1.1 Global Artificial Intelligence in Diabetes Management Forecast by Regions (2025-2030)
10.1.2 Americas Artificial Intelligence in Diabetes Management Forecast
10.1.3 APAC Artificial Intelligence in Diabetes Management Forecast
10.1.4 Europe Artificial Intelligence in Diabetes Management Forecast
10.1.5 Middle East & Africa Artificial Intelligence in Diabetes Management Forecast
10.2 Americas Artificial Intelligence in Diabetes Management Forecast by Country (2025-2030)
10.2.1 United States Artificial Intelligence in Diabetes Management Market Forecast
10.2.2 Canada Artificial Intelligence in Diabetes Management Market Forecast
10.2.3 Mexico Artificial Intelligence in Diabetes Management Market Forecast
10.2.4 Brazil Artificial Intelligence in Diabetes Management Market Forecast
10.3 APAC Artificial Intelligence in Diabetes Management Forecast by Region (2025-2030)
10.3.1 China Artificial Intelligence in Diabetes Management Market Forecast
10.3.2 Japan Artificial Intelligence in Diabetes Management Market Forecast
10.3.3 Korea Artificial Intelligence in Diabetes Management Market Forecast
10.3.4 Southeast Asia Artificial Intelligence in Diabetes Management Market Forecast
10.3.5 India Artificial Intelligence in Diabetes Management Market Forecast
10.3.6 Australia Artificial Intelligence in Diabetes Management Market Forecast
10.4 Europe Artificial Intelligence in Diabetes Management Forecast by Country (2025-2030)
10.4.1 Germany Artificial Intelligence in Diabetes Management Market Forecast
10.4.2 France Artificial Intelligence in Diabetes Management Market Forecast
10.4.3 UK Artificial Intelligence in Diabetes Management Market Forecast
10.4.4 Italy Artificial Intelligence in Diabetes Management Market Forecast
10.4.5 Russia Artificial Intelligence in Diabetes Management Market Forecast
10.5 Middle East & Africa Artificial Intelligence in Diabetes Management Forecast by Region (2025-2030)
10.5.1 Egypt Artificial Intelligence in Diabetes Management Market Forecast
10.5.2 South Africa Artificial Intelligence in Diabetes Management Market Forecast
10.5.3 Israel Artificial Intelligence in Diabetes Management Market Forecast
10.5.4 Turkey Artificial Intelligence in Diabetes Management Market Forecast
10.5.5 GCC Countries Artificial Intelligence in Diabetes Management Market Forecast
10.6 Global Artificial Intelligence in Diabetes Management Forecast by Type (2025-2030)
10.7 Global Artificial Intelligence in Diabetes Management Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Apple
11.1.1 Apple Company Information
11.1.2 Apple Artificial Intelligence in Diabetes Management Product Offered
11.1.3 Apple Artificial Intelligence in Diabetes Management Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Apple Main Business Overview
11.1.5 Apple Latest Developments
11.2 Diabnext
11.2.1 Diabnext Company Information
11.2.2 Diabnext Artificial Intelligence in Diabetes Management Product Offered
11.2.3 Diabnext Artificial Intelligence in Diabetes Management Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Diabnext Main Business Overview
11.2.5 Diabnext Latest Developments
11.3 Glooko
11.3.1 Glooko Company Information
11.3.2 Glooko Artificial Intelligence in Diabetes Management Product Offered
11.3.3 Glooko Artificial Intelligence in Diabetes Management Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Glooko Main Business Overview
11.3.5 Glooko Latest Developments
11.4 Google
11.4.1 Google Company Information
11.4.2 Google Artificial Intelligence in Diabetes Management Product Offered
11.4.3 Google Artificial Intelligence in Diabetes Management Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Google Main Business Overview
11.4.5 Google Latest Developments
11.5 IBM
11.5.1 IBM Company Information
11.5.2 IBM Artificial Intelligence in Diabetes Management Product Offered
11.5.3 IBM Artificial Intelligence in Diabetes Management Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 IBM Main Business Overview
11.5.5 IBM Latest Developments
11.6 Tidepool
11.6.1 Tidepool Company Information
11.6.2 Tidepool Artificial Intelligence in Diabetes Management Product Offered
11.6.3 Tidepool Artificial Intelligence in Diabetes Management Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Tidepool Main Business Overview
11.6.5 Tidepool Latest Developments
11.7 Vodafone
11.7.1 Vodafone Company Information
11.7.2 Vodafone Artificial Intelligence in Diabetes Management Product Offered
11.7.3 Vodafone Artificial Intelligence in Diabetes Management Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Vodafone Main Business Overview
11.7.5 Vodafone Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂